|
UNITED
STATES |
OMB APPROVAL |
|
OMB Number: 3235-0582 |
|
|
Expires: April 30, 2009 |
|
|
Estimated average burden hours per response........14.4 |
FORM N-PX
ANNUAL
REPORT OF PROXY VOTING RECORD OF REGISTERED
MANAGEMENT INVESTMENT COMPANY
Investment Company Act file number 811- 04889
H&Q Healthcare Investors
(Exact name of registrant as specified in charter)
2 Liberty Square, 9th Floor, Boston, MA |
|
02109 |
(Address of principal executive offices) |
|
(Zip code) |
Laura Woodward
H&Q Healthcare Investors
2 Liberty Square, 9th Floor, Boston MA 02109
(Name and address of agent for service)
Registrants telephone number, including area code: 617 772-8500
Date of fiscal year end: September 30
Date of reporting period: 7/1/08-6/30/09
Form N-PX is to be used by a registered management investment company, other than a small business investment company registered on Form N-5 (ss.ss.239.24 and 274.5 of this chapter), to file reports with the Commission, not later than August 31 of each year, containing the registrants proxy voting record for the most recent twelve-month period ended June 30, pursuant to section 30 of the Investment Company Act of 1940 and rule 30b1-4 thereunder (17 CFR 270.30b1-4). The Commission may use the information provided on Form N-PX in its regulatory, disclosure review, inspection, and policymaking roles.
A registrant is required to disclose the information specified by Form N-PX, and the Commission will make this information public. A registrant is not required to respond to the collection of information contained in Form N-PX unless the Form displays a currently valid Office of Management and Budget (OMB) control number. Please direct comments concerning the accuracy of the information collection burden estimate and any suggestions for reducing the burden to the Secretary, Securities and Exchange Commission, 450 Fifth Street, NW, Washington, DC 20549-0609. The OMB has reviewed this collection of information under the clearance requirements of 44 U.S.C. ss. 3507.
Item 1. Proxy Voting Record.
HQH N-PX for the period July 1, 2008 to June 30, 2009
CUSIP |
|
Symbol |
Company Name |
|
|
||
004225108 |
|
ACAD |
ACADIA Pharmaceuticals Inc. |
|
|
||
Meeting Date: |
6/12/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
4/13/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Uli Hacksell |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Torsten Rasmussen |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Alan Walton |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
To ratify the selection of PricewaterhouseCoopers LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2009 |
|
For |
|
Yes |
|
For |
|
Management |
00817Y108 |
|
AET |
Aetna Inc. |
|
|
||
Meeting Date: |
5/29/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/27/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Frank M. Clark |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Betsy Z. Cohen |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Molly J. Coye, MD |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Roger N. Farah |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Barbara Hackman Franklin |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Jeffrey E. Garten |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Earl G. Graves |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Gerald Greenwald |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Ellen M. Hancock |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Richard J. Harrington |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Edward J. Ludwig |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Joseph P. Newhouse |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Ronald A. Williams |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Approval of indepdent registered public accounting firm |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
Shareholder proposal on cumulative voting |
|
Against |
|
Yes |
|
Against |
|
Stockholder |
4 |
|
Shareholder proposal on nominating a retired Aetna executive to the board |
|
Against |
|
Yes |
|
Against |
|
Stockholder |
00826A109 |
|
AFFY |
Affymax, Inc. |
|
|
||
Meeting Date: |
5/28/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/31/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Ted W. Love, MD |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Arlene M. Morris |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Daniel K. Spiegelman |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
To ratify the selection of Ernst & Young LLP as independent registered public accounting firm of Affymax for its fiscal year ending December 31, 2009 |
|
For |
|
Yes |
|
For |
|
Management |
015351109 |
|
ALXN |
Alexion Pharmaceuticals, Inc. |
|
|
||
Meeting Date: |
5/13/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/24/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Leonard Bell |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Max Link |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Joseph A. Madri |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Larry L. Mathis |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director R. Douglas Norby |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Alvin S. Parven |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Ruedi E. Waeger |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Ratification of appointment by the board of directors of PricewaterhouseCoopers LLP as Alexions independent registered public accounting firm |
|
For |
|
Yes |
|
For |
|
Management |
016255101 |
|
ALGN |
Align Technology, Inc. |
|
|
||
Meeting Date: |
5/21/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/27/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director David E. Collins |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Joseph Lacob |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director C. Raymond Larkin, Jr. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director George J. Morrow |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Thomas M. Prescott |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Greg J. Santora |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Warren S. Thaler |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Proposal to ratify the appointment of PricewaterhouseCoopers LLP as Align Technology, Inc.s independent registered public accountants for the fiscal year ending December 31, 2009 |
|
For |
|
Yes |
|
For |
|
Management |
2
01642T108 |
|
ALKS |
Alkermes, Inc. |
|
|
||
Meeting Date: |
10/7/2008 |
|
Meeting Type: |
Annual |
|||
Record Date: |
7/14/2008 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Floyd E. Bloom |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Robert A. Breyer |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Geraldine Henwood |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Paul J. Mitchell |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Richard F. Pops |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Alexander Rich |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Dvid A. Broeckert |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Mark B. Skaletsky |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Michael A. Wall |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director David W. Anstice |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
To approve the Alkermes 2008 stock option and incentive plan |
|
For |
|
Yes |
|
Against |
|
Management |
3 |
|
To ratify PricewaterhouseCoopers LLP as the companys independent registered public accountant for fiscal year 2009 |
|
For |
|
Yes |
|
For |
|
Management |
031162100 |
|
AMGN |
Amgen Inc. |
|
|
||
Meeting Date: |
5/6/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/9/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Dr. David Baltimore |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Frank J. Biondi, Jr. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Francois de Carbonnel |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Jerry D. Choate |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Dr. Vance D. Coffman |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Frederick W. Gluck |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Frank C. Herringer |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Dr. Gilbert S. Omenn |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Judity C. Pelham |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Adm. J. paul Reason, UsN |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Leonard D. Schaeffer |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Kevin W. Sharer |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
To ratify the selection of Ernst & Young LLP as our independent registered public accountants for the year ending December 31, 2009 |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
To approve the proposed 2009 equity incentive plan, which authorizes the issuance of 100,000,000 shares |
|
For |
|
Yes |
|
For |
|
Management |
4 |
|
To approve the proposed amendment to our restated certificate of incorporation, as amended, which reduces the sixty-six and two-thirds percent voting requirement to a simple majority voting requirement for approval of certain business combinations |
|
For |
|
Yes |
|
For |
|
Management |
5 |
|
Stockholder proposal #1 to amend our bylaws to permit 10% of our outstanding common stock the ability to call special meetings |
|
Against |
|
Yes |
|
Against |
|
Stockholder |
5 |
|
Stockholder proposal #2 to change our jurisdiction of incorporation from Delaware to North Dakota |
|
Against |
|
Yes |
|
Against |
|
Stockholder |
3
032346108 |
|
AMLN |
Amylin Pharmaceuticals, Inc. |
|
|
||
Meeting Date: |
5/27/2009 |
|
Meeting Type: |
Annual - Contested |
|||
Record Date: |
4/8/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director M. Kathleen Behrens |
|
Unkown |
|
Yes |
|
For |
|
Opposition |
1 |
|
Elect director Charles M. Fleischman |
|
Unkown |
|
Yes |
|
For |
|
Opposition |
1 |
|
Elect director Jay Sherwood |
|
Unkown |
|
Yes |
|
Withhold |
|
Opposition |
1 |
|
Elect director Dr. A.J. Denner |
|
Unkown |
|
Yes |
|
Withhold |
|
Opposition |
1 |
|
Elect director Dr. T.F. Deuel |
|
Unkown |
|
Yes |
|
Withhold |
|
Opposition |
1 |
|
Elect director Adrian Adams |
|
Unkown |
|
Yes |
|
For |
|
Opposition |
1 |
|
Elect director Teresa Beck |
|
Unkown |
|
Yes |
|
For |
|
Opposition |
1 |
|
Elect director D.M. Bradbury |
|
Unkown |
|
Yes |
|
For |
|
Opposition |
1 |
|
Elect director Paul N. Clark |
|
Unkown |
|
Yes |
|
For |
|
Opposition |
1 |
|
Elect director Paulo F. Costa |
|
Unkown |
|
Yes |
|
For |
|
Opposition |
1 |
|
Elect director Karin Eastham |
|
Unkown |
|
Yes |
|
For |
|
Opposition |
1 |
|
Elect directo Jay S. Skyler |
|
Unkown |
|
Yes |
|
For |
|
Opposition |
2 |
|
Proposal to adopt the companys 2009 equity incentive plan as described in the proxy statement |
|
Unkown |
|
Yes |
|
For |
|
Opposition |
3 |
|
2001 employee stock purchase plan proposal as described in the proxy statement |
|
Unkown |
|
Yes |
|
For |
|
Opposition |
4 |
|
Proposal to ratify Ernst & Young LLP as the independent public registered accounting firm for Amylin for the year ending December 31, 2009 |
|
Unkown |
|
Yes |
|
For |
|
Opposition |
5 |
|
Icahn reincorporation proposal as described in the proxy statement |
|
Unkown |
|
Yes |
|
Against |
|
Opposition |
032346108 |
|
AMLN |
Amylin Pharmaceuticals, Inc. |
|
|
||
Meeting Date: |
5/27/2009 |
|
Meeting Type: |
Annual - Contested |
|||
Record Date: |
4/8/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Adrian Adams |
|
For |
|
No |
|
None |
|
Management |
1 |
|
Elect director Steven R. Altman |
|
For |
|
No |
|
None |
|
Management |
1 |
|
Elect director Teresa Beck |
|
For |
|
No |
|
None |
|
Management |
1 |
|
Elect director Daniel M. Bradbury |
|
For |
|
No |
|
None |
|
Management |
1 |
|
Elect director Paul N. Clark |
|
For |
|
No |
|
None |
|
Management |
1 |
|
Elect director Joseph C. Cook, Jr. |
|
For |
|
No |
|
None |
|
Management |
1 |
|
Elect director Paulo F. Costa |
|
For |
|
No |
|
None |
|
Management |
1 |
|
Elect director Karin Eastham |
|
For |
|
No |
|
None |
|
Management |
1 |
|
Elect director James R. Gavin III |
|
For |
|
No |
|
None |
|
Management |
1 |
|
Elect director Jay S. Skyler |
|
For |
|
No |
|
None |
|
Management |
1 |
|
Elect director Joseph P. Sullivan |
|
For |
|
No |
|
None |
|
Management |
1 |
|
Elect director James N. Wilson |
|
For |
|
No |
|
None |
|
Management |
2 |
|
To approve the companys 2009 equity incentive plan |
|
For |
|
No |
|
None |
|
Management |
3 |
|
To approve an increase of 1,500,000 shares in the aggregate number of shares of the companys common stock authorized for issuance under the companys 2001 employee stock purchase plan |
|
For |
|
No |
|
None |
|
Management |
4 |
|
To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm of the company for its fiscal year ending December 31, 2009 |
|
For |
|
No |
|
None |
|
Management |
5 |
|
Stockholder proposal to change the companys jurisdiction of incorporation from Delaware to North Dakota |
|
Against |
|
No |
|
None |
|
Stockholder |
4
032346108 |
|
AMLN |
Amylin Pharmaceuticals, Inc. |
|
|
||
Meeting Date: |
5/27/2009 |
|
Meeting Type: |
Annual - Contested |
|||
Record Date: |
4/8/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Alexander J. Denner |
|
Unkown |
|
No |
|
None |
|
Opposition |
1 |
|
Elect director Thomas F. Deuel |
|
Unkown |
|
No |
|
None |
|
Opposition |
1 |
|
Elect director M.K. Behrens |
|
Unkown |
|
No |
|
None |
|
Opposition |
1 |
|
Elect director C.M. Fleischman |
|
Unkown |
|
No |
|
None |
|
Opposition |
1 |
|
Elect director Jay Sherwood |
|
Unkown |
|
No |
|
None |
|
Opposition |
1 |
|
Elect director Adrian Adams |
|
Unkown |
|
No |
|
None |
|
Opposition |
1 |
|
Elect director Teresa Beck |
|
Unkown |
|
No |
|
None |
|
Opposition |
1 |
|
Elect director D.M. Bradbury |
|
Unkown |
|
No |
|
None |
|
Opposition |
1 |
|
Elect director Paul N. Clark |
|
Unkown |
|
No |
|
None |
|
Opposition |
1 |
|
Elect director Paulo F. Costa |
|
Unkown |
|
No |
|
None |
|
Opposition |
1 |
|
Elect director Karin Eastham |
|
Unkown |
|
No |
|
None |
|
Opposition |
1 |
|
Elect director Jay S. Skyler |
|
Unkown |
|
No |
|
None |
|
Opposition |
2 |
|
Amylins equity incentive plan |
|
Unkown |
|
No |
|
None |
|
Opposition |
3 |
|
Amendment to the 2001 employee stock purchase plan |
|
Unkown |
|
No |
|
None |
|
Opposition |
4 |
|
Ratification of appointment of independent registered public accounting firm |
|
Unkown |
|
No |
|
None |
|
Opposition |
5 |
|
North Dakota reincorporation proposal |
|
Unkown |
|
No |
|
None |
|
Stockholder |
038149100 |
|
ABI |
Applied Biosystems Inc. |
|
|
||
Meeting Date: |
10/16/2008 |
|
Meeting Type: |
Special |
|||
Record Date: |
9/5/2008 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Approve and adopt the agreement and plan of merger, as amended, by and among Invitrogen Corporation, Atom Acquisition, LLC, and Applied Biosystems Inc., as such agreement may be amended from time to time, and to approve the merger of Applied Biosystems Inc. with and into Atom Acquisition, LLC, all as more fully described in the proxy statement |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
To adjourn the Applied Biosystems Inc. special meeting of stockholders, if necessary, to solicit additional proxies if there are not sufficient votes for the foregoing proposal |
|
For |
|
Yes |
|
For |
|
Management |
04744L106 |
|
ATHX |
Athersys, Inc. |
|
|
||
Meeting Date: |
6/18/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
4/24/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Gil Van Bokkelen |
|
For |
|
No |
|
None |
|
Management |
1 |
|
Elect director Jordan S. Davis |
|
For |
|
No |
|
None |
|
Management |
1 |
|
Elect director John J. Harrington |
|
For |
|
No |
|
None |
|
Management |
1 |
|
Elect director Floyed D. Loop |
|
For |
|
No |
|
None |
|
Management |
1 |
|
Elect director George M. Milne, Jr. |
|
For |
|
No |
|
None |
|
Management |
1 |
|
Elect director William C. Mulligan |
|
For |
|
No |
|
None |
|
Management |
1 |
|
Elect director Lorin J. Randall |
|
For |
|
No |
|
None |
|
Management |
1 |
|
Elect director Michael Sheffery |
|
For |
|
No |
|
None |
|
Management |
2 |
|
Ratification for Ernst & Young LLP as auditors |
|
For |
|
No |
|
None |
|
Management |
5
05334D107 |
|
AUXL |
Auxilium Pharmaceuticals, Inc. |
|
|
||
Meeting Date: |
6/10/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
4/16/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Rolf A. Classon |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Al Altomari |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Armando Anido |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Edwin A. Bescherer, Jr. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director P.O. Chambon, MD, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Oliver S. Fetzer, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Renato Fuchs, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Dennis Langer, MD, JD |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director William T. McKee |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Approve amendment and restatement of Auxilium Pharmaceuticals, Inc. 2004 equity compensation plan to increase number of shares of company common stock authorized for issuance under the plan by 2,650,000 shares from 8,000,000 to 10,650,000 shares, subject to limitation that of those 2,650,000 shares only 700,000 shares may be issued pursuant to stock awards, stock units |
|
For |
|
Yes |
|
For |
|
Management |
4 |
|
To ratify the selection by the audit and compliance committee of the companys board of directors of PricewaterhouseCoopers LLP as the companys independent registered public accounting firm for the fiscal year ending December 31, 2009 |
|
For |
|
Yes |
|
For |
|
Management |
05346P106 |
|
AVRX |
Avalon Pharmaceuticals, Inc. |
|
|
||
Meeting Date: |
5/28/2009 |
|
Meeting Type: |
Special |
|||
Record Date: |
4/13/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
To consider and vote upon a proposal to adopt the agreement and plan of merger and reorganization, dated as of October 27, 2008, as amended, by and among Clinical Data, Inc., API Acquisition Sub II, LLC, and Avalon Pharmaceuticals, Inc., pursuant to which API will merge with and into Avalon, with Avalon being the surviving corporation |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
To consider and vote upon a proposal to adjourn the special meeting to a later date or time, if necessary or appropriate, to solicit additional proxies in the event there are insufficient votes at the time of the special meeting to adopt the merger agreement |
|
For |
|
Yes |
|
For |
|
Management |
6
068306109 |
|
BRL |
Barr Pharmaceuticals, Inc. |
|
|
||
Meeting Date: |
11/21/2008 |
|
Meeting Type: |
Special |
|||
Record Date: |
10/10/2008 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Adoption of the agreement and plan of merger, dated as of July 18, 2008 by and among Barr Pharmaceuticals, Inc., Teva Pharmaceutical Industries, Ltd. and Boron Acquisition Corp., as it may be amended from time to time |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Approval of the adjournment of the special meeting, if necessary or appropriate, to solicit additional proxies if there are insufficient votes at the time of the special meeting to adopt the agreement and plan of merger referred to in proposal 1 |
|
For |
|
Yes |
|
For |
|
Management |
09062X103 |
|
BIIB |
Biogen Idec |
|
|
||
Meeting Date: |
6/3/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
4/6/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Lawrence C. Best |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Alan B. Glassberg |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Robert W. Pangia |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director William D. Young |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
To ratify the selection of PricewaterhouseCoopers LLP as the companys independent registered public accounting firm for the fiscal year ending December 31, 2009 |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
To approve amendments to the companys bylaws to change the voting standard for the election of directors in uncontested elections from a plurality to a majority standard |
|
For |
|
Yes |
|
For |
|
Management |
4 |
|
Shareholder proposal to amend the companys bylaws to fix the size of the board at 13 members and remove the boards ability to change the size of the board |
|
Against |
|
Yes |
|
Against |
|
Stockholder |
5 |
|
Shareholder proposal that the company reincorporate from Deleware to North Dakota and elect to be subject to the North Dakota publicly traded corporations act |
|
Against |
|
Yes |
|
Against |
|
Stockholder |
09062X103 |
|
BIIB |
Biogen Idec |
|
|
||
Meeting Date: |
6/3/2009 |
|
Meeting Type: |
Annual - Contested |
|||
Record Date: |
4/6/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Alexander J. Denner |
|
Unkown |
|
No |
|
None |
|
Opposition |
1 |
|
Elect director Richard C. Mulligan |
|
Unkown |
|
No |
|
None |
|
Opposition |
1 |
|
Elect director Thomas F. Deuel |
|
Unkown |
|
No |
|
None |
|
Opposition |
1 |
|
Elect director David Sidransky |
|
Unkown |
|
No |
|
None |
|
Opposition |
2 |
|
Approval of the Icahn bylaws amendments |
|
Unkown |
|
No |
|
None |
|
Opposition |
3 |
|
Approval of the North Dakota Reincorporation resolution |
|
Unkown |
|
No |
|
None |
|
Opposition |
4 |
|
Ratification of independent registered public accounting firm |
|
Unkown |
|
No |
|
None |
|
Opposition |
5 |
|
Approval of the Biogen bylaw amendment |
|
Unkown |
|
No |
|
None |
|
Opposition |
7
14159L103 |
|
BEAT |
CardioNet, Inc. |
|
|
||
Meeting Date: |
10/23/2008 |
|
Meeting Type: |
Annual |
|||
Record Date: |
9/10/2008 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect Director Ronald A. Ahrens |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect Fred Middleton |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
To ratify the selection by the Audit Committee of our board of directors of Ernst & Young LLP as our independent auditors for the fiscal year ending December 31, 2008 |
|
For |
|
Yes |
|
For |
|
Management |
14159L103 |
|
BEAT |
CardioNet, Inc. |
|
|
||
Meeting Date: |
5/8/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/16/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Randy H. Thurman |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Kirk E. Gorman |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
To ratify the selection by the audit committee of the board of directors of Ernst & Young LLP as the independent auditors for the fiscal year ending December 31, 2009 |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
To approve an amendment to the CardioNet, Inc. 2008 non-employee directors stock option plan and all outstanding options granted thereunder to date to extend the post-termination exercise period for vested options from three months following directors termination of service to the remainder of the option term in effect at the time of the directors termination of service |
|
For |
|
Yes |
|
Against |
|
Management |
14888B103 |
|
CHSI |
Catalyst Health Solutions Inc. |
|
|
||
Meeting Date: |
6/1/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
4/3/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Steven B. Epstein |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Michael R. McDonnell |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Dale B. Wolf |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
The approval of reservation of additional 100,000 shares of company stock for issuance under the companys 2004 employee stock purchase plan |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
The ratification of the appointment of PricewaterhouseCoopers LLP as independent registered public accountants of Catalyst Health Solutions, Inc. for the fiscal year ending December 31, 2009 |
|
For |
|
Yes |
|
For |
|
Management |
8
151020104 |
|
CELG |
Celgene Corporation |
|
|
||
Meeting Date: |
6/17/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
4/21/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Sol J. Barer, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Robert J. Hugin |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Michael D. Casey |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Rodman L. Drake |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director A.H. Hayes, Jr., MD |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Gilla Kaplan, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director James J. Loughlin |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Ernest Mario, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Walter L. Robb, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Ratification of the appointment of KPMG LLP as the companys independent registered public accounting firm for the fiscal year ending December 31, 2009 |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
Approval of an amendment and restatement of the companys 2008 stock incentive plan |
|
For |
|
Yes |
|
For |
|
Management |
4 |
|
Stockholder proposal regarding the voting standard for director elections |
|
Against |
|
Yes |
|
Against |
|
Stockholder |
156708109 |
|
CEPH |
Cephalon, Inc. |
|
|
||
Meeting Date: |
5/12/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/17/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director F. Baldino, Jr., Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director William P. Egan |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Martyn D. Greenacre |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Vaughn M. Kailian |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Kevin E. Moley |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director C.A. Sanders, MD |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Gail R. Wilensky, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Dennis L. Winger |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Approval of amendment to the 2004 equity compensation plan increasing the number of shares authorized for issuance |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
Ratification of the appointment of PricewaterhouseCoopers LLP as independent registered public accountants for the year ending December 31, 2009 |
|
For |
|
Yes |
|
For |
|
Management |
9
N/A |
|
N/A |
Concentric Medical, Inc. |
|
|
|
Action by Written Consent: |
12/15/2008 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Approval of amended and restated certificate of incorporation |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Approval of issuance of preferred stock |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
Approval of waiver of right of first refusal |
|
For |
|
Yes |
|
For |
|
Management |
4 |
|
Approval of increase to stock plan |
|
For |
|
Yes |
|
For |
|
Management |
5 |
|
Approval of indemnification agreements |
|
For |
|
Yes |
|
For |
|
Management |
6 |
|
Omnibus resolution |
|
For |
|
Yes |
|
For |
|
Management |
222083107 |
|
CGRB |
Cougar Biotechnology, Inc. |
|
|
||
Meeting Date: |
10/28/2008 |
|
Meeting Type: |
Special |
|||
Record Date: |
9/9/2008 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Approval of proposed amendments to the companys 2003 stock option plan as described in the accompanying proxy statement |
|
For |
|
Yes |
|
For |
|
Management |
229678107 |
|
CBST |
Cubist Pharmaceuticals, Inc. |
|
|
||
Meeting Date: |
6/4/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
4/9/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Kenneth Bate |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Nancy Hutson |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Martin Soeters |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
A proposal to amend the amended and restated 1997 employee stock purchase plan, or ESPP, to increase the number of shares issuable under the ESPP by 500,000 |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
A proposal to amend out amended and restated 2002 directors equity incentive plan to extend the term of the directors plan by 3 years and to increase the number of shares issuable under the directors plan by 400,000 |
|
For |
|
Yes |
|
For |
|
Management |
4 |
|
A proposal to ratify the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2009 |
|
For |
|
Yes |
|
For |
|
Management |
10
122650100 |
|
CVS |
CVS Caremark Corporation |
|
|
||
Meeting Date: |
5/6/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/12/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Edwin M. Banks |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director C. David Brown II |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director David W. Dorman |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Kristen G. Williams |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Marian L. Heard |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director William H. Joyce |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Jean-Pierre Millon |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Terrence Murray |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director C.A. Lance Piccolo |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Sheli Z. Rosenberg |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Thomas M. Ryan |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Richard J. Swift |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Proposal to ratify the appointment of Ernst & Young LLP as the companys independent registered public accounting firm for the 2009 fiscal year |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
Stockholder proposal regarding special stockholder meetings |
|
Against |
|
Yes |
|
For |
|
Stockholder |
4 |
|
Stockholder proposal regarding independent chairman of the board |
|
Against |
|
Yes |
|
For |
|
Stockholder |
5 |
|
Stockholder proposal regarding political contributions and expenditures |
|
Against |
|
Yes |
|
For |
|
Stockholder |
6 |
|
Stockholder proposal regarding advisory stockholder vote on executive compensation |
|
Against |
|
Yes |
|
For |
|
Stockholder |
278856109 |
|
ECLP |
Eclipsys Corp. |
|
|
||
Meeting Date: |
5/13/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/20/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director John T. Casey |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Jay B. Pieper |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
To ratify the selection of PricewaterhouseCoopers LLP by the board of directors as the companys independent registered public accounting firm for the current fiscal year |
|
For |
|
Yes |
|
For |
|
Management |
N/A |
|
N/A |
Eleme Medical, Inc. |
|
|
|
Action by Written Consent: |
8/1/2008 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Approval of amendment to certificate of incorporation |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Approval of general authorization |
|
For |
|
Yes |
|
For |
|
Management |
11
30161Q104 |
|
EXEL |
Exelixis, Inc. |
|
|
||
Meeting Date: |
5/13/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/16/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Charles Cohen, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director George Poste, DVM, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Jack L. Wyszomierski |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
To ratify the selection of Ernst & Young LLP as Exelixis independent registered public accounting firm for the fiscal year ending January 1, 2010 |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
To approve an amendment to the Exelixis, Inc. 2000 employee stock purchase plan to increase the number of shares of common stock reserved for issuance under the 2000 employee stock purchase plan by 5,000,000 shares |
|
For |
|
Yes |
|
Against |
|
Management |
4 |
|
To approve the amendment and restatement of the Exelixis, Inc. 2000 equity incentive plan |
|
For |
|
Yes |
|
Against |
|
Management |
5 |
|
To approve a proposed exchange of certain outstanding stock options for a reduced number of replacement stock options to be granted under the 2000 equity incentive plan with an exercise price equal to the fair market value of Exelixis common stock at the time of the exchange |
|
For |
|
Yes |
|
For |
|
Management |
N/A |
|
N/A |
FlowCardia, Inc. |
|
|
|
Action by Written Consent: |
3/3/2009 |
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Approval of amendment to amend and restated equity incentive plan |
|
For |
|
No |
|
None |
|
Management |
2 |
|
General authority and ratification |
|
For |
|
No |
|
None |
|
Management |
345838106 |
|
FRX |
Forest Laboratories, Inc. |
|
|
||
Meeting Date: |
8/11/2008 |
|
Meeting Type: |
Annual |
|||
Record Date: |
6/19/2008 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
1 |
|
Elect director Howard Solomon |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director L.S. Olanoff, MD, Ph.D. |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Nesli Basgoz, MD |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director William J. Candee, III |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director George S. Cohan |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Dan L. Goldwasser |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Kenneth E. Goodman |
|
For |
|
Yes |
|
For |
|
Management |
1 |
|
Elect director Lester B. Salans, MD |
|
For |
|
Yes |
|
For |
|
Management |
2 |
|
Adoption of the amended and restated certificate of incorporation |
|
For |
|
Yes |
|
For |
|
Management |
3 |
|
Ratification of BDO Seidman, LLP as independent registered public acocunting firm |
|
For |
|
Yes |
|
For |
|
Management |
12
372917104 |
|
GENZ |
Genzyme Coporation |
|
|
||
Meeting Date: |
5/21/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/31/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect director Douglas A. Berthiaume |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Gail K. Boudreaux |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Robert J. Carpenter |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Charles L. Cooney |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Victor J. Dzau |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Senator Connie Mack III |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Richard F. Syron |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Henri A. Termeer |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
A proposal to amend the 2004 equity incentive plan to increase the number of shares of common stock available for issuance under the plan by 2,500,000 shares |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
A proposal to approve the 2009 employee stock purchase plan |
|
For |
|
Yes |
|
For |
|
Management |
|
4 |
|
A proposal to ratify the audit committees selection of independent auditors for 2009 (PricewaterhouseCoopers LLP) |
|
For |
|
Yes |
|
For |
|
Management |
|
375558103 |
|
GILD |
Gilead Sciences, Inc. |
|
|
||
Meeting Date: |
5/6/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
3/9/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect director Paul Berg |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director John F. Cogan |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Etienne F. Davignon |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director James M. Denny |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Carla A. Hills |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director John W. Madigan |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director John C. Martin |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Gordon E. Moore |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Nicholas G. Moore |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Richard J. Whitley |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Gayle E. Wilson |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To ratify the selection of Ernst & Young LLP by the audit committee of the board of directors as the independent registered public accounting firm of Gilead for the fiscal year ending December 31, 2009 |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
To approve an amendment to Gileads 2004 equity incentive plan |
|
For |
|
Yes |
|
For |
|
Management |
|
13
436440101 |
|
HOLX |
Hologic, Inc. |
|
|
||
Meeting Date: |
3/4/2009 |
|
Meeting Type: |
Annual |
|||
Record Date: |
1/16/2009 |
|
|
|
|||
# |
|
Proposal |
|
Mgt. Recommends |
|
Voted |
|
Vote Cast |
|
Sponsor |
|
1 |
|
Elect director John W. Cumming |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Robert A. Cascella |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director David R. Lavance, Jr. |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Nancy L. Leaming |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Lawrence M. Levy |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Glenn P. Muir |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Elaine S. Ullian |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Sally W. Crawford |
|
For |
|
Yes |
|
For |
|
Management |
|
1 |
|
Elect director Wayne Wilson |
|
For |
|
Yes |
|
For |
|
Management |
|
2 |
|
To consider and act upon a stock option exchange program for eligible employees |
|
For |
|
Yes |
|
For |
|
Management |
|
3 |
|
To consider and act upon the adjournment of the annual meeting, including if necessary, to solicit additional proxies in favor of the foregoing proposals, as described in the accompanying proxy statement |
|
For |
|
Yes |
|
For |
|
Management |
|
45103T107 |
|
ICLR |
Icon Plc |
|
|
||
Meeting Date: |
7/21/2008 |
|
Meeting Type: |
Annual |
|||
Record Date: |
N/A |
|
|
|
|||